Bee Venom Allergy
📧 Sign up to get email alerts when something new happens for Bee Venom Allergy.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2025-12-30Clinical Trial Update: Study to Assess the Safety and Effectiveness of Beltaven® in Patients With Allergy to Apis Mellifera, Polistes Dominula or Vespula Spp.
A clinical trial is recruiting to evaluate the safety and effectiveness of Beltaven for individuals with bee venom allergy due to Apis melli…
-
CLINICAL_TRIALS research · 2025-12-08Clinical Trial Update: Predominant Sensitizations to Single Bee Venom Allergens as a Risk Factor for Therapy Failure
A clinical study funded by the Medical University of Graz is examining whether sensitization to single bee venom allergens increases the ris…
-
CLINICAL_TRIALS trial_result · 2016-11-21Clinical Trial Update: Omalizumab Treatment in Venom Immunotherapy With Systemic Reactions [NA]
This clinical trial update discusses the use of omalizumab as part of venom immunotherapy for bee venom allergy, with the trial status liste…
-
CLINICAL_TRIALS trial_result · 2013-03-04Clinical Trial Update: Efficacy and Safety of a Purified Standardised Bee Venom Preparation [Phase 3]
Phase 3 trial evaluating efficacy and safety of a purified standardised bee venom preparation for bee venom allergy has completed. The docum…
-
CLINICAL_TRIALS trial_result · 2008-05-26Clinical Trial Update: Maintenance Bee-Venom Immunotherapy Administered at 6-Month Intervals Does Not Protect Against re-Stings [Phase 4]
A Phase 4 trial found that maintenance bee-venom immunotherapy given every six months did not protect against subsequent bee stings in peopl…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.